Vimarsana
Biggest News Aggregation in the World

Susannah Cantrell News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Susannah Cantrell. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Susannah Cantrell Today - Breaking & Trending Today

Brii Biosciences Provides Corporate Update and Reports Full-Year 2022 Financial Results - Vimarsana News

Brii Biosciences Provides Corporate Update and Reports Full-Year 2022 Financial Results

/PRNewswire/ -- Brii Biosciences Limited ("Brii Bio," "we," or the "Company", stock code: 2137.HK), a biotechnology company developing therapies to improve...

Brii Biosciences Appoints Dr. Susannah Cantrell as Chief Business Officer - Vimarsana News

Brii Biosciences Appoints Dr. Susannah Cantrell as Chief Business Officer

Brii Biosciences Appoints Dr. Susannah Cantrell as Chief Business Officer - read this article along with other careers information, tips and advice on BioSpace

Brii Biosciences Appoints Dr. Susannah Cantrell as Chief Business Officer - Vimarsana News

Brii Biosciences Appoints Dr. Susannah Cantrell as Chief Business Officer

Strategic executive hire adds to Company's global leadership team and positions the Company for continued growth DURHAM, N.C.and BEIJING, July 13, 2022 /PRNewswire/ --Brii Biosciences Limited("Brii Bio" or the "Company", stock code: 2137.HK) a multi-national company developing innovative therapies for diseases with significant unmet medical needs and large public health burdens, today announced the appointment of Susannah Cantrell, Ph.D., as Chief Business Officer. Dr. Cantrell brings with her more than 20 years of healthcare and biotechnology industry experience spanni...

Second Genome Announces Bayer Exercised Option Following Completion of Multi-Year Collaboration - Vimarsana News

Second Genome Announces Bayer Exercised Option Following Completion of Multi-Year Collaboration

/PRNewswire/ -- Second Genome, a biotechnology company that leverages its proprietary platform to discover and develop precision therapies and biomarkers,...

Second Genome Announces Bayer Exercised Option Following Completion of Multi-Year Collaboration - Vimarsana News

Second Genome Announces Bayer Exercised Option Following Completion of Multi-Year Collaboration

/PRNewswire/ -- Second Genome, a biotechnology company that leverages its proprietary platform to discover and develop precision therapies and biomarkers,...